MedAptus Funding: How Much Did They Raise & Key Investors

How Much Did MedAptus Raise?
Funding & Key Investors

MedAptus, a provider of healthcare revenue cycle and patient assignment software, has secured significant enterprise-level funding, with its total funding amount currently standing at $8.9M. The company recently announced a major strategic investment of $350K, underscoring its pivotal role in enhancing revenue capture and streamlining clinical workflows within the healthcare sector.

The company's solutions are designed to integrate with Electronic Health Records (EHR) systems, automating charge capture, optimizing patient assignments, and improving the accuracy of infusion coding. This strategic financing is expected to fuel further development and market expansion for MedAptus's suite of products, including Charge Pro, Assign, and Charge Infusion.

What is MedAptus?

MedAptus

Software

Healthcare Software

MedAptus specializes in developing advanced software solutions for the healthcare revenue cycle and patient assignment processes. Their technology suite is engineered to address critical challenges faced by hospitals and physician groups, aiming to reduce administrative burdens and enhance the efficiency of patient care delivery. By leveraging intelligent automation, MedAptus empowers healthcare organizations to improve their financial performance and focus resources on providing high-quality patient services. The company's commitment to innovation in revenue cycle management positions it as a key player in the health-tech industry.

How much funding has MedAptus raised?

MedAptus has raised a total of $8.8M across 3 funding rounds:

2000

Series A

$2.5M

2009

Unspecified

$6M

2020

Debt

$350K

Series A (2000): $2.5M with participation from Leo Capital Holdings

Unspecified (2009): $6M led by Boston Millennia Partners

Debt (2020): $350K supported by PPP

Key Investors in MedAptus

Boston Millennia Partners

Boston Millennia Partners is a private equity firm with a focus on high-growth companies within the healthcare and life sciences sectors, bringing extensive experience in finance and operations to its portfolio companies.

Leo Capital Holdings

Leo Capital Holdings is a venture investor that targets early and later-stage private companies, with a primary focus on consumer-oriented technology and applications in large markets.

What's next for MedAptus?

With the recent injection of major strategic capital, MedAptus is poised for accelerated growth and enhanced market penetration. The company is likely to focus on expanding its product offerings, further integrating its solutions with a wider range of EHR systems, and potentially exploring new healthcare verticals. This strategic investment signals strong confidence from backers in MedAptus's business model and its capacity to address complex revenue cycle challenges. Future developments may include advancements in AI-driven analytics for revenue optimization and enhanced patient assignment algorithms, solidifying MedAptus's position as a leader in healthcare technology innovation.

See full MedAptus company page

See More Financial Insights